Abstract:Recently, the original paper entitled “Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia” reported by Yong-Kang Tao and colleagues attracted our interest [ [1] Tao Y.K. Zeng H. Zhang G.Q. Chen S.T. Xie X.J. He X. et al. Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia. Int. J. Cardiol. 2017; 236: 413-422 Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar ]. Their results revealed that Notch3 deficiency reduced cardiac pericyte coverage, impaired coronary blood flow reserve, and ultimately increased ischemic area post myocardial infarction (MI) via inhibiting CXCR4/SDF-1α and VEGF/Ang-1 signaling pathways [ [1] Tao Y.K. Zeng H. Zhang G.Q. Chen S.T. Xie X.J. He X. et al. Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia. Int. J. Cardiol. 2017; 236: 413-422 Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar ]. Therefore, Notch3 might be a novel therapeutic approach to MI centered at increasing pericyte/progenitor cell recruitment and vascular maturation. Cardiac fibrosis which is characterized by excessive deposition of scar tissue significantly reduces cardiac function after MI [ [2] Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010; 106: 1675-1680 Crossref PubMed Scopus (549) Google Scholar ]. Thus, anti-fibrotic therapy is promising in curbing fibrosis and enhancing cardiac function after MI [ [3] Sassoli C. Chellini F. Pini A. Tani A. Nistri S. Nosi D. et al. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-beta/Smad3 signaling. PLoS One. 2013; 8e63896 Crossref PubMed Scopus (111) Google Scholar ]. Zhang et al. demonstrated that Notch3 inhibited cardiac fibroblast-myofibroblast transition in MI mice and in cultured CFs with TGF-β1 stimulus by inhibiting TGF-β1/Smad3 signaling pathway to reduce cardiac fibrosis [ [4] Zhang M. Pan X. Zou Q. Xia Y. Chen J. Hao Q. et al. Notch3 ameliorates cardiac fibrosis after myocardial infarction by inhibiting the TGF-beta1/Smad3 pathway. Cardiovasc. Toxicol. 2016; 16: 316-324 Crossref PubMed Scopus (35) Google Scholar ]. Zhang et al. also reported that Oncostatin M (OSM) significantly alleviated cardiac ischemia/reperfusion (I/R) injury via Notch3/Akt signaling pathway. OSM receptor Oβ knockout also promoted cardiomyocyte apoptosis, impaired mitochondrial function, exacerbated I/R injury, and inhibited Notch3 production. However, Notch3 overexpression alleviated, while Notch3 siRNA treatment aggravated cardiac I/R injury in mice [ [5] Zhang M. Wang C. Hu J. Lin J. Zhao Z. Shen M. et al. Notch3/Akt signaling contributes to OSM-induced protection against cardiac ischemia/reperfusion injury. Apoptosis. 2015; 20: 1150-1163 Crossref PubMed Scopus (26) Google Scholar ]. Collectively, these findings supported that Notch3 is a potential therapeutic target for ischemic heart diseases by promoting pericyte/progenitor cell recruitment and vascular maturation, inhibiting cardiac fibrosis, improving mitochondrial function, and alleviating cardiac dysfunction. Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemiaInternational Journal of CardiologyVol. 236PreviewVascular maturation plays an important role in wound repair post-myocardial infarction (MI). The Notch3 is critical for pericyte recruitment and vascular maturation during embryonic development. Full-Text PDF

Notch Signaling Promotes Angiogenesis and Improves Cardiac Function after Myocardial Infarction

Notch Signaling Activation Contributes to Cardioprotection Provided by Ischemic Preconditioning and Postconditioning.

Notch1 Cardioprotection in Myocardial Ischemia/reperfusion Involves Reduction of Oxidative/nitrative Stress

Angiogenin Gene Transfer Improves Left Ventricular Function in Rats with Myocardial Infarction

Notch 1 Signalling Inhibits Cardiomyocyte Apoptosis in Ischaemic Postconditioning

Activated Notch1 reduces myocardial ischemia reperfusion injury in vitro during ischemic postconditioning by crosstalk with the RISK signaling pathway.

Abstract 12099: Activated Notch1 Interacting with LKB1 Reduces Myocardial Ischemic Injury Via Modulating AMPK Signaling Pathway

Nogo-B promotes angiogenesis and improves cardiac repair after myocardial infarction via activating Notch1 signaling

A Potential and Novel Therapeutic Approach to Ischemic Heart Diseases: Notch3.

Blockade of the Notch Signaling Pathway Promotes M2 Macrophage Polarization to Suppress Cardiac Fibrosis Remodeling in Mice With Myocardial Infarction

[The Effect of Notch1 on Myocardial Ischemia Reperfusion Injury].

Cardioprotective Actions of Notch1 Against Myocardial Infarction Via LKB1-dependent AMPK Signaling Pathway

Role of Notch signaling in the mammalian heart.

Notch1-Nrf2 signaling crosstalk provides myocardial protection by reducing ROS formation

Notch1 provides myocardial protection by improving mitochondrial quality control

The Role ofNotch 1Activation in Cardiosphere Derived Cell Differentiation

Notch1 Signaling Activation Protected Myocardium Against Hypoxia Injury Via Reducing Programmed Cell Death.

Notch1 protects against myocardial ischaemia-reperfusion injury via regulating mitochondrial fusion and function

The role of notch 1 activation in cardiosphere derived cell differentiation.

Mir-210 Activates Notch Signaling Pathway in Angiogenesis Induced by Cerebral Ischemia

Notch Signaling Inhibits Cardiac Fibroblast To Myofibroblast Transformation By Antagonizing Tgf-Beta 1/Smad3 Signaling